Symbols / WHWK $3.39 -4.51% Whitehawk Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
WHWK Chart
About

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 160.00M
Enterprise Value 21.85M Income -20.60M Sales 7.14M
Book/sh 2.89 Cash/sh 3.09 Dividend Yield —
Payout 0.00% Employees 23 IPO —
P/E — Forward P/E -2.83 PEG —
P/S 22.39 P/B 1.17 P/C —
EV/EBITDA -0.19 EV/Sales 3.06 Quick Ratio 10.04
Current Ratio 10.26 Debt/Eq — LT Debt/Eq —
EPS (ttm) -0.33 EPS next Y -1.20 EPS Growth —
Revenue Growth -100.00% Earnings 2026-05-07 ROA -64.66%
ROE -21.82% ROIC — Gross Margin 0.00%
Oper. Margin -16.01% Profit Margin -288.26% Shs Outstand 47.20M
Shs Float 17.43M Short Float 2.04% Short Ratio 4.31
Short Interest — 52W High 4.48 52W Low 1.39
Beta 0.62 Avg Volume 161.77K Volume 67.55K
Target Price $5.67 Recom Buy Prev Close $3.55
Price $3.39 Change -4.51%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.67
Mean price target
2. Current target
$3.39
Latest analyst target
3. DCF / Fair value
$-20.46
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.39
Low
$4.00
High
$7.00
Mean
$5.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-22 init Jones Trading — → Buy $7
News
RSS: Latest WHWK news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-08 LENNON DAVID JAMES Chief Executive Officer — 260,427 $3.40 $899,538
2026-04-02 LENNON DAVID JAMES Chief Executive Officer — 26,858 $3.48 $93,466
2026-04-01 GIACOBELLO SCOTT M Chief Financial Officer — 473,902 — —
2026-04-01 BALL BRYAN Officer — 366,532 — —
2026-04-01 LENNON DAVID JAMES Chief Executive Officer — 775,828 — —
2026-03-02 GIACOBELLO SCOTT M Chief Financial Officer — 2,594 $3.31 $8,585
2026-03-02 BALL BRYAN Officer — 1,834 $3.31 $6,070
2026-03-02 LENNON DAVID JAMES Chief Executive Officer — 5,100 $3.31 $16,879
2026-02-27 GIACOBELLO SCOTT M Chief Financial Officer — 6,750 — —
2026-02-27 BALL BRYAN Officer — 5,000 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
7.14
-72.50%
25.98
+6.69%
24.35
+60.06%
15.22
Operating Revenue
7.14
-72.50%
25.98
+6.69%
24.35
+60.06%
15.22
Cost Of Revenue
0.76
-74.87%
3.02
+7.65%
2.81
+110.41%
1.33
Reconciled Cost Of Revenue
0.76
-74.87%
3.02
+7.65%
2.81
+110.41%
1.33
Gross Profit
6.38
-72.19%
22.96
+6.56%
21.55
+55.21%
13.88
Operating Expense
120.78
+37.60%
87.78
-6.10%
93.48
+28.34%
72.84
Research And Development
90.96
+78.25%
51.03
+4.29%
48.93
+49.80%
32.66
Selling General And Administration
29.82
-18.85%
36.75
-17.51%
44.55
+10.88%
40.18
General And Administrative Expense
—
—
—
—
Other Gand A
—
—
—
—
Other Operating Expenses
—
—
—
—
Total Expenses
121.55
+33.86%
90.80
-5.70%
96.29
+29.81%
74.17
Operating Income
-114.40
-76.49%
-64.82
+9.89%
-71.93
-22.01%
-58.96
Total Operating Income As Reported
-114.40
-69.59%
-67.46
+6.22%
-71.93
-14.76%
-62.68
EBITDA
-20.52
+67.61%
-63.34
+3.09%
-65.36
-8.72%
-60.12
Normalized EBITDA
-107.79
-77.57%
-60.70
+7.13%
-65.36
-15.89%
-56.40
Reconciled Depreciation
0.08
-59.07%
0.19
+14.20%
0.17
+6.29%
0.16
EBIT
-20.60
+67.58%
-63.54
+3.05%
-65.53
-8.71%
-60.28
Total Unusual Items
87.27
+3403.22%
-2.64
-264100.00%
-0.00
+99.97%
-3.72
Total Unusual Items Excluding Goodwill
87.27
+3403.22%
-2.64
-264100.00%
-0.00
+99.97%
-3.72
Special Income Charges
87.27
+3408.04%
-2.64
0.00
+100.00%
-3.72
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
—
0.00
-100.00%
3.72
Restructuring And Mergern Acquisition
0.00
-100.00%
2.64
0.00
—
Net Income
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Pretax Income
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Net Non Operating Interest Income Expense
6.23
+65.23%
3.77
-38.87%
6.17
+184.55%
2.17
Interest Expense Non Operating
0.00
-100.00%
0.15
-33.33%
0.23
+0.43%
0.23
Net Interest Income
6.23
+65.23%
3.77
-38.87%
6.17
+184.55%
2.17
Interest Expense
0.00
-100.00%
0.15
-33.33%
0.23
+0.43%
0.23
Interest Income Non Operating
6.23
+58.75%
3.92
-38.67%
6.40
+166.89%
2.40
Interest Income
6.23
+58.75%
3.92
-38.67%
6.40
+166.89%
2.40
Other Income Expense
87.57
+3414.65%
-2.64
-264100.00%
-0.00
+99.97%
-3.72
Other Non Operating Income Expenses
0.30
—
—
—
Gain On Sale Of Security
0.01
+225.00%
-0.00
-300.00%
-0.00
—
Gain On Sale Of Business
87.27
0.00
—
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Net Income From Continuing Operation Net Minority Interest
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Net Income From Continuing And Discontinued Operation
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Net Income Continuous Operations
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Normalized Income
-107.87
-76.69%
-61.05
+7.17%
-65.76
-15.80%
-56.79
Net Income Common Stockholders
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Diluted EPS
-0.33
+86.02%
-2.36
+3.28%
-2.44
+9.29%
-2.69
Basic EPS
-0.33
+86.02%
-2.36
+3.28%
-2.44
+9.29%
-2.69
Basic Average Shares
61.89
+128.96%
27.03
+0.42%
26.92
+19.58%
22.51
Diluted Average Shares
61.89
+128.96%
27.03
+0.42%
26.92
+19.58%
22.51
Diluted NI Availto Com Stockholders
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Preferred Stock Dividends
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
150.83
+114.49%
70.32
-46.90%
132.42
-28.12%
184.24
Current Assets
149.01
+143.14%
61.29
-50.81%
124.59
-30.80%
180.03
Cash Cash Equivalents And Short Term Investments
145.70
+208.44%
47.24
-56.60%
108.84
-36.92%
172.56
Cash And Cash Equivalents
37.57
+31.04%
28.67
-54.41%
62.89
+61.17%
39.02
Other Short Term Investments
108.13
+482.37%
18.57
-59.60%
45.96
-65.59%
133.54
Receivables
0.00
-100.00%
5.90
+7.56%
5.49
+194.74%
1.86
Accounts Receivable
0.00
-100.00%
5.90
+7.56%
5.49
+194.74%
1.86
Gross Accounts Receivable
—
6.00
+5.54%
5.69
—
Allowance For Doubtful Accounts Receivable
—
-0.10
+50.00%
-0.20
—
Inventory
0.00
-100.00%
5.31
-17.36%
6.43
+245.35%
1.86
Raw Materials
0.00
-100.00%
3.53
-23.86%
4.64
+391.53%
0.94
Work In Process
0.00
0.00
-100.00%
1.37
0.00
Finished Goods
0.00
-100.00%
1.78
+322.33%
0.42
-54.09%
0.92
Prepaid Assets
—
—
—
—
Other Current Assets
3.32
+16.93%
2.84
-25.88%
3.83
+2.14%
3.75
Total Non Current Assets
1.82
-79.88%
9.03
+15.25%
7.84
+86.24%
4.21
Net PPE
0.00
-99.96%
7.63
+27.83%
5.97
+194.14%
2.03
Gross PPE
0.38
-95.34%
8.10
+29.72%
6.24
+192.87%
2.13
Accumulated Depreciation
-0.37
+19.22%
-0.46
-71.48%
-0.27
-167.33%
-0.10
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.00
-100.00%
0.79
-32.68%
1.17
-23.19%
1.52
Machinery Furniture Equipment
0.38
-29.53%
0.54
+1.13%
0.53
+31.27%
0.40
Construction In Progress
0.00
-100.00%
6.59
+50.15%
4.39
+5600.00%
0.08
Other Properties
—
0.05
+104.00%
0.03
-98.36%
1.52
Leases
0.00
-100.00%
0.13
+3.10%
0.13
+0.00%
0.13
Goodwill And Other Intangible Assets
—
—
—
0.00
Other Intangible Assets
—
—
—
—
Other Non Current Assets
1.81
+29.66%
1.40
-25.03%
1.87
-14.33%
2.18
Total Liabilities Net Minority Interest
14.52
-18.62%
17.84
-34.48%
27.23
+5.29%
25.86
Current Liabilities
14.52
-14.96%
17.07
-35.31%
26.39
+40.14%
18.84
Payables And Accrued Expenses
11.36
-32.15%
16.74
-26.83%
22.88
+76.30%
12.98
Payables
0.92
-57.53%
2.16
-81.48%
11.65
+231.20%
3.52
Accounts Payable
0.92
-57.53%
2.16
-63.39%
5.90
+67.60%
3.52
Other Payable
—
—
5.76
—
Current Accrued Expenses
10.44
-28.40%
14.58
+29.92%
11.22
+18.67%
9.46
Pensionand Other Post Retirement Benefit Plans Current
3.16
+4837.50%
0.06
-97.92%
3.08
-43.60%
5.46
Current Debt And Capital Lease Obligation
—
0.27
-38.25%
0.43
+10.15%
0.39
Current Capital Lease Obligation
0.00
-100.00%
0.27
-38.25%
0.43
+10.15%
0.39
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.77
-7.92%
0.83
-88.14%
7.02
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.56
-32.17%
0.83
-34.25%
1.27
Long Term Capital Lease Obligation
0.00
-100.00%
0.56
-32.17%
0.83
-34.25%
1.27
Tradeand Other Payables Non Current
—
—
0.00
0.00
Other Non Current Liabilities
—
0.20
—
—
Stockholders Equity
136.31
+159.75%
52.48
-50.11%
105.19
-33.58%
158.38
Common Stock Equity
136.31
+159.75%
52.48
-50.11%
105.19
-33.58%
158.38
Capital Stock
0.00
+100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
47.15
+91.02%
24.68
+0.52%
24.55
+0.49%
24.44
Ordinary Shares Number
47.15
+91.02%
24.68
+0.52%
24.55
+0.49%
24.44
Additional Paid In Capital
489.44
+27.09%
385.11
+2.94%
374.13
+3.44%
361.69
Retained Earnings
-353.25
-6.19%
-332.65
-23.68%
-268.96
-32.36%
-203.20
Gains Losses Not Affecting Retained Earnings
0.12
+650.00%
0.02
-40.74%
0.03
+123.48%
-0.12
Other Equity Adjustments
0.12
+650.00%
0.02
-40.74%
0.03
+123.48%
-0.12
Total Equity Gross Minority Interest
136.31
+159.75%
52.48
-50.11%
105.19
-33.58%
158.38
Total Capitalization
136.31
+159.75%
52.48
-50.11%
105.19
-33.58%
158.38
Working Capital
134.49
+204.20%
44.21
-54.97%
98.19
-39.09%
161.19
Invested Capital
136.31
+159.75%
52.48
-50.11%
105.19
-33.58%
158.38
Total Debt
0.00
-100.00%
0.83
-34.25%
1.27
-23.72%
1.66
Capital Lease Obligations
0.00
-100.00%
0.83
-34.25%
1.27
-23.72%
1.66
Net Tangible Assets
136.31
+159.75%
52.48
-50.11%
105.19
-33.58%
158.38
Tangible Book Value
136.31
+159.75%
52.48
-50.11%
105.19
-33.58%
158.38
Dueto Related Parties Current
—
—
5.76
0.00
Dueto Related Parties Non Current
—
—
0.00
-100.00%
5.76
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-97.43
-63.62%
-59.55
+0.19%
-59.66
-20.19%
-49.64
Cash Flow From Continuing Operating Activities
-97.43
-63.62%
-59.55
+0.19%
-59.66
-20.19%
-49.64
Net Income From Continuing Operations
-20.60
+67.66%
-63.69
+3.15%
-65.77
-8.68%
-60.51
Depreciation Amortization Depletion
0.08
-59.07%
0.19
+14.20%
0.17
+6.29%
0.16
Depreciation And Amortization
0.08
-59.07%
0.19
+14.20%
0.17
+6.29%
0.16
Other Non Cash Items
0.07
-83.91%
0.46
-11.37%
0.52
+35.86%
0.38
Stock Based Compensation
9.87
-8.91%
10.84
-9.33%
11.95
+23.97%
9.64
Asset Impairment Charge
—
—
0.00
-100.00%
3.72
Operating Gains Losses
-87.27
—
—
—
Unrealized Gain Loss On Investment Securities
—
—
—
0.00
Change In Working Capital
1.93
+131.90%
-6.05
-77.73%
-3.40
-87.03%
-1.82
Change In Receivables
-1.00
-140.96%
-0.41
+88.55%
-3.63
-94.74%
-1.86
Changes In Account Receivables
-1.00
-140.96%
-0.41
+88.55%
-3.63
-94.74%
-1.86
Change In Inventory
0.17
-84.77%
1.12
+134.18%
-3.27
-75.44%
-1.86
Change In Prepaid Assets
-0.43
-115.42%
2.81
-21.90%
3.60
+346.27%
-1.46
Change In Payables And Accrued Expense
3.92
+140.14%
-9.77
-7303.79%
-0.13
-104.10%
3.22
Change In Payable
—
—
—
—
Change In Account Payable
—
—
—
—
Change In Other Current Assets
-0.44
-184.56%
0.52
+0.00%
0.52
+18.54%
0.44
Change In Other Current Liabilities
-0.29
+6.13%
-0.31
+38.25%
-0.50
-72.51%
-0.29
Investing Cash Flow
11.89
-52.82%
25.20
-69.71%
83.21
+162.61%
-132.89
Cash Flow From Continuing Investing Activities
11.89
-52.82%
25.20
-69.71%
83.21
+162.61%
-132.89
Net PPE Purchase And Sale
-0.55
+66.63%
-1.65
+58.36%
-3.97
-794.59%
-0.44
Purchase Of PPE
-0.55
+66.63%
-1.65
+58.36%
-3.97
-794.59%
-0.44
Capital Expenditure
-0.55
+66.63%
-1.65
+58.36%
-3.97
-794.59%
-0.44
Net Investment Purchase And Sale
-88.84
-430.81%
26.86
-69.19%
87.18
+165.82%
-132.44
Purchase Of Investment
-148.69
-307.57%
-36.48
+43.39%
-64.44
+55.62%
-145.19
Sale Of Investment
59.84
-5.51%
63.34
-58.23%
151.62
+1089.15%
12.75
Net Business Purchase And Sale
101.29
0.00
—
0.00
Purchase Of Business
—
—
—
0.00
Gain Loss On Sale Of Business
-87.27
—
—
—
Financing Cash Flow
94.38
+72496.92%
0.13
-60.12%
0.33
-99.55%
72.62
Cash Flow From Continuing Financing Activities
94.38
+72496.92%
0.13
-60.12%
0.33
-99.55%
72.62
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
100.00
0.00
0.00
-100.00%
72.50
Cash Dividends Paid
—
—
—
0.00
Proceeds From Stock Option Exercised
0.07
-48.63%
0.15
-69.96%
0.49
-37.61%
0.78
Net Other Financing Charges
-5.70
-35531.25%
-0.02
+90.00%
-0.16
+75.72%
-0.66
Changes In Cash
8.83
+125.82%
-34.22
-243.36%
23.87
+121.72%
-109.91
Beginning Cash Position
28.73
-54.36%
62.95
+61.07%
39.08
-73.77%
148.99
End Cash Position
37.57
+30.74%
28.73
-54.36%
62.95
+61.07%
39.08
Free Cash Flow
-97.98
-60.10%
-61.20
+3.82%
-63.63
-27.06%
-50.08
Interest Paid Supplemental Data
0.00
-100.00%
0.21
-8.26%
0.23
+0.00%
0.23
Amortization Of Securities
-1.53
-17.37%
-1.30
+58.51%
-3.14
-158.11%
-1.22
Common Stock Issuance
100.00
0.00
0.00
-100.00%
72.50
Issuance Of Capital Stock
100.00
0.00
0.00
-100.00%
72.50
Sale Of Business
101.29
0.00
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category